ARGORNA Trademark

Trademark Overview


On Tuesday, December 6, 2022, a trademark application was filed for ARGORNA with the United States Patent and Trademark Office. The USPTO has given the ARGORNA trademark a serial number of 79368771. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by ARGORNA PHARMACEUTICALS CO., LTD. The ARGORNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; vaccines; drugs for medical purposes, namely, pharmaceuticals for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biological preparations for medical purposes, for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; medicines for human purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; raw material medicine, namely, insulin; biochemical medicines for th...
argorna

General Information


Serial Number79368771
Word MarkARGORNA
Filing DateTuesday, December 6, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435586
Registration DateTuesday, July 9, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; vaccines; drugs for medical purposes, namely, pharmaceuticals for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biological preparations for medical purposes, for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; medicines for human purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; raw material medicine, namely, insulin; biochemical medicines for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameARGORNA PHARMACEUTICALS CO., LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameARGORNA PHARMACEUTICALS CO., LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameARGORNA PHARMACEUTICALS CO., LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, May 4, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 9, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Sunday, September 17, 2023NON-FINAL ACTION WRITTEN
Monday, September 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 28, 2023REFUSAL PROCESSED BY MPU
Thursday, September 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 17, 2023REFUSAL PROCESSED BY IB
Thursday, January 11, 2024NON-FINAL ACTION WRITTEN
Friday, February 2, 2024NON-FINAL ACTION MAILED
Thursday, March 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 18, 2024REFUSAL PROCESSED BY IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOTIFICATION PROCESSED BY IB
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 20, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 20, 2024FINAL DISPOSITION PROCESSED
Friday, January 10, 2025FINAL DECISION TRANSACTION PROCESSED BY IB